The University of California, San Diego recently received a $12.5 million grant from the National Institutes of Health to fund Alzheimer’s disease research. The 2014 study was awarded life science research funding from the administering institute: National Institute on Aging. Dr. Paul Aisen, the project leader, joined the Department of Neurosciences at UCSD in 2007. Before being appointed director of the Alzheimer’s Disease Cooperative Study (ADCS) at the University of California, San Diego, he was a professor of neurology and medicine and director of the Memory Disorders Program at Georgetown University School of Medicine.
“The overall aim of the ADCS is to advance research in the development of interventions that might be useful for treating, delaying, or preventing AD, particularly interventions that might not be developed by industry,” stated by the researchers on the NIH project information page. “In particular, the ADCS has focused on instrument and trial methodology, and the testing of potential therapeutics that might not otherwise be studied by the pharmaceutical industry. For the coming grant cycle, the ADCS will continue its efforts to advance therapeutics through controlled clinical trials, development of novel instruments and trial designs, recruitment efforts (with particular attention to recruitment of minority subjects). The organization will continue its recent emphasis on collaboration and data sharing.”
Specific aim for Dr. Aisen and University of California, San Diego research lab scientists hope to meet include:
- Testing interventions to deter the onset of Alzheimer’s disease
- Testing interventions to lessen the effects of behavioral symptoms
- Designing new instruments to use in clinical trials
- Developing new approaches to Alzheimer’s disease clinical trial design
- Developing new approaches to Alzheimer’s disease clinical trial analysis
- Broadening the scope of patients tested in Alzheimer’s disease clinical trials to include at-risk individuals and those with MCI
- Including minority groups in Alzheimer’s disease studies
The University of California, San Diego Medical Center
Research lab scientists at the University of California, San Diego receive one of the highest amounts of life science research funding in the country. In 2013, the National Institutes of Health gave the University of California, San Diego $362 million in science research grants. UCSD also received $1 billion in research funding in fiscal year 2012-2013, an increase of nearly $50 million over the previous year. The University of California, San Diego has obtained $4.9 billion in research funding over the past five years and raises an average of $82 million in new grants per month.
Given the staggering amount of life science research funding University of California, San Diego research lab scientists receive, lab suppliers on the West Coast may want to increase their brand recognition at this well-funded research institution. On August 28th, 2014, Biotechnology Calendar, Inc. will host our Biotechnology Vendor Showcase™ Event at the University of California, San Diego. Last year, this event drew crowds of over 600 attendees, of which 214 were purchasing agents, professors and post docs, and 83 were lab managers.
Biotechnology Calendar, Inc. is a full-service science research marketing and events-planning company that organizes vendor shows at universities where research lab scientists receive a wealth of life science research funding. If you are interested in exhibiting at a vendor show closer to home, we encourage you to view our 2014 calendar of events. For more information on the Biotechnology Vendor Showcase™ Event at the University of California, San Diego, or to get more funding statistics for UCSD, click on the button below.
